1. Home
  2. HITI vs VYGR Comparison

HITI vs VYGR Comparison

Compare HITI & VYGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo High Tide Inc.

HITI

High Tide Inc.

HOLD

Current Price

$2.46

Market Cap

189.8M

Sector

N/A

ML Signal

HOLD

Logo Voyager Therapeutics Inc.

VYGR

Voyager Therapeutics Inc.

HOLD

Current Price

$3.40

Market Cap

203.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HITI
VYGR
Founded
2009
2013
Country
Canada
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
189.8M
203.6M
IPO Year
2021
2015

Fundamental Metrics

Financial Performance
Metric
HITI
VYGR
Price
$2.46
$3.40
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
2
Target Price
$6.13
$16.50
AVG Volume (30 Days)
394.0K
507.0K
Earning Date
06-15-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$10,135,000.00
Revenue This Year
$23.73
$34.04
Revenue Next Year
$12.80
$7.92
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.02
$2.94
52 Week High
$4.06
$5.55

Technical Indicators

Market Signals
Indicator
HITI
VYGR
Relative Strength Index (RSI) 67.72 58.55
Support Level $2.35 $3.29
Resistance Level $2.54 $4.31
Average True Range (ATR) 0.08 0.14
MACD 0.02 0.04
Stochastic Oscillator 87.27 89.00

Price Performance

Historical Comparison
HITI
VYGR

About HITI High Tide Inc.

High Tide Inc is a downstream-focused retailer of cannabis products, distributor, and seller of smoking accessories and cannabis lifestyle products. It is a vertically integrated company in the Canadian cannabis market with various brands in its portfolio such as Canna Cabana, Fastendr, Queen of Bud, Grasscity, Daily High Club, and others. The company's reportable operating segments are: Bricks and mortar, which generates maximum revenue, and E-commerce. Geographically, it derives maximum revenue from its business in Canada, followed by the United States of America, and other international markets.

About VYGR Voyager Therapeutics Inc.

Voyager Therapeutics Inc is a biotechnology company to leverage the power of human genetics to modify the course of and ultimately cure neurological diseases. Its pipeline includes programs for Alzheimer's disease, or AD; Friedreich's ataxia, or FA; Parkinson's disease, or PD; and multiple other diseases of the central nervous system, or CNS. Many of its programs are derived from its TRACER (Tropism Redirection of AAV by Cell-type-specific Expression of RNA) adeno-associated virus, or AAV, capsid discovery platform, which the company has used to generate novel capsids, or TRACER Capsids, and identify associated receptors to potentially enable high brain penetration with genetic medicines following intravenous, or IV, dosing. Its segment is developing and commercializing genetic medicine.

Share on Social Networks: